LED Medical Diagnostics Inc TSXV: LMD / OTCQX:LEDID FORWARD-LOOKING - - PowerPoint PPT Presentation

led medical diagnostics inc
SMART_READER_LITE
LIVE PREVIEW

LED Medical Diagnostics Inc TSXV: LMD / OTCQX:LEDID FORWARD-LOOKING - - PowerPoint PPT Presentation

LED Medical Diagnostics Inc TSXV: LMD / OTCQX:LEDID FORWARD-LOOKING STATEMENTS The contents of this presentation are for information purposes only. This presentation is not to be construed as an offering of securities. Certain information


slide-1
SLIDE 1

LED Medical Diagnostics Inc

TSXV: LMD / OTCQX:LEDID

slide-2
SLIDE 2

The contents of this presentation are for information purposes only. This presentation is not to be construed as an offering of securities. Certain information contained in this presentation of LED Medical Diagnostics Inc. (the “Company”) constitutes “forward-looking statements“ within the meaning of securities laws. Actual events or results could differ materially from expectations and projections. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intent”, “estimate”, “anticipate”, “believe”, “should”, “plans”, or “continue”, or similar expressions suggesting future outcomes or events. Forward-looking statements include, but are not limited to, statements regarding LED’s future plans, strategies, objectives, performance, revenues, growth, profits, operating expenses or LED’s underlying assumptions, LED’s plans to optimize current relationships and VELscope sales channels and LED’s intention to expand its technology beyond dental applications. Persons reading this presentation are cautioned that such statements or information are only predictions, and that LED’sactualfuture results orperformance maybe materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to: history of losses; the risk of material adverse effects in relation to a warning letter issued by the United States Food and Drug Administration, uncertainty of additional financing; third party product risks; regulatory risk; intellectual property risk; economic conditions; dilution; limited history of operations; operational risk; distributor risks; working capital; potential conflicts of interest; speculative investment; disruptions in production; equipment leases; reliance on key personnel and employees; seasonality; management’s estimates; development of new customers and products risks; stock price volatility risk; sales and marketing risk; competitors and competition risk; changes in barriers to entry for the market; regulatory requirements; reliance on few suppliers; reliance on subcontractors; operating cost and quarterly results fluctuations; fluctuations in exchange rates; fluctuations in interest rates; product liability and medical malpractice claims; access to credit and additional financing; taxation; market acceptance of LED’s products and services; customer and industry analyst perception of LED and its technology vision and future prospects; technological change, new products and standards; risks related to acquisitions and international expansion; reliance on large customers; concentration of sales; international operations and sales; management of growth and expansion; dependence upon key personnel and hiring; LED not adequately protecting its intellectual property; risks related to product defects and product liability; and including, but not limited to, other factors described in the preliminary short form prospectus and the documents incorporated by reference therein. In drawing a conclusion or making a forecast or projection set out in the forward-looking information, LED takes into account the following material factors and assumptions in addition to the above factors: LED’s ability to execute on its business plan; the acceptance of LED’s products and services by its customers; the timing of execution of outstanding or potential customer contracts by LED; the sales opportunities available to LED; LED’s subjective assessment of the likelihood of success of a sales lead or opportunity; LED’s historic ability to generate sales leads or opportunities; and that sales will be completed at or above LED’s estimated margins. This list is not exhaustive of the factors that may affect LED’s forward-looking information. Theseand otherfactorsshould be consideredcarefully and readers should not place unduereliance on suchforward-lookinginformation. Except as required by law, the Company disclaims any intention or obligation to update or revise the forward-looking information, whether as a result of new information, future events or otherwise. The forward-lookingstatementsin this documentareprovided for the limited purpose of enabling potential investors to evaluatean investmentin the securitiesof the Company. In this presentation, all references to dollars or“$” are to the lawful currencyof Canada and all amountsare in Canadian dollars, unless otherwise indicated.

FORWARD-LOOKING STATEMENTS

2

slide-3
SLIDE 3

WHO WE ARE

LED Dental is a technology company that combines a unique offering of best in class dental imaging software and hardware device solutions andservices

3

Proprietary technologies include:

  • Apteryx suite of open architecture imaging software systems
  • Industry's first cloud based SaaS imaging module
  • VELscope and TUXEDO sensor devices imaging devices

The Company has experienced rapid growth since 2013 and the recent acquisition positions LED to become a leading player in the US dental imaging market

slide-4
SLIDE 4

KEY INVESTMENT CONSIDERATION

Industry’s first affordable cloud based SaaS imaging module adding high value recurring revenue – key product in rapidly growing Dental Service Organizations (large group) market

4

Recent transformative accretive acquisition adding thousands of dentist customers, extensive IP portfolio and patented imaging software suite Dental technology company with significant opportunity for revenue, EBITDA and cash flow growth Market share growth to be driven by leveraging newly acquired customer base, SaaS based platform and unique blend of leading hardware solutions through established sales and marketing and distribution channels US market for dental digital imaging is world’s largest and growing with market estimated to exceed $1.7B by 2020

slide-5
SLIDE 5

To leverage the Apteryx brand equity, user base and established distribution channels to drive software and image devicesales

5

Rapid customer acquisition and recurring revenue addition through targeting DSO with dual offering Align with large distribution partners for XV Web SaaS offering and device distribution bundle

AN ENHANCED BUSINESS STRATEGY

slide-6
SLIDE 6

APTERYX OPEN SOFTWARE ARCHITECTURE

3rd Party Dental Practice Management Software 3rd Party Dental Imaging Hardware Devices

6

  • Patented integration with wide variety of imaging devices and management software applications
slide-7
SLIDE 7

COMPETITIVE ADVANTAGES

7 Patent protected “capture to cloud” Picture Archiving System (PACS) offering available in dental industry at affordable subscription price “Open architected patented software solutions that integrate with a wide variety

  • f imaging devices and dental management software systems

Ability to leverage the joint sales, distribution and marketing efforts of both LED and Apteryx Ability to cross sell hardware and software products to dental practitioners and DSO’s Proven management and software development teams in niche market Strong intellectual property portfolio - 28 issued digital imaging related patents Large “already digital” customer base

slide-8
SLIDE 8

SALES & DISTRIBUTION

8

Hybrid sales approach, direct and distributor sales model Sales teams can cross sell Apteryx Software with LED dental devices and products More attractive offering for customers for integration purposes and ease of use dealing with one vendor Apteryx software currently installed in tens of thousands of US dental offices – key relationships and trust established Targeting US based Dental Service Organizations (DSOs), currently representing 25%

  • f dental offices and Dental Specialties (Ortho, Oral Surgery & Periodontics)
slide-9
SLIDE 9

PRODUCT PORTFOLIO

PATENTED

  • VELscope Vx

PROPRIETARY

  • LED TUXEDO Sensor
  • Next Generation
  • Subscription Bundle

LICENSED

  • RAYSCAN α
  • LED IC100 / IC200
  • 3 ShapeTRIOS

PATENTED

  • APTERYX
  • XrayVision

DCV

  • XrayVision
  • XV Lite
  • XV Web

9

slide-10
SLIDE 10

3rd Party Service Providers Cloud Management Software Dental Lab Services Radiology / Oral Medicine Insurance

LED IMAGING ECOSYSTEM

10

  • LED’s open architected “end to end” integrated imaging solution
slide-11
SLIDE 11

HISTORICAL REVENUE GROWTH

2013 2014 2015 2016 2017 US$2.5M US$13.1M US$10M US$9.0 M

Current management joined in early 2014 and led consistent YOY growth

11

2016 balance sheet weakness and focus on Apteryx acquisition impacted the year 2017 EXPECTING SIGNIFICANT BOUNCE BACK

slide-12
SLIDE 12

EXECUTIVE MANAGEMENT

  • Dr. David Gane | CEO

12

  • Extensive experience in the dental imaging industry in senior executive management positions
  • Former Vice President, Dental Imaging, for Kodak Dental Systems & Carestream Dental LLC (a daughter company
  • f Carestream Health LLC)
  • Accomplished dental surgeon and a recognized dental imaging expert
  • Drive and passion for dental imaging technology, along with experience and distinctive management style
  • Mr. Lamar Roberts | President
  • Responsible for implementing and overseeing the growth programs of some of the largest companies in the

medical technology industry

  • Developed an industry reputation for guiding companies from early growth stages to becoming industry leaders
  • Held several senior executive positions with leaders in the dental industry, including, 360imaging, Carestream

Dental and PracticeWorks

  • Strong background in leading commercial efforts in technical, medical, and geographically dispersed organizations
  • Mr. Kevin Crucs | Vice President R&D | LED Medical Diagnostics
  • Founder and former President of Apteryx, Inc.
  • Over 30 years of experience in software engineering and product development
  • Over 20 years of experience in dental imaging, technologies and integrations
slide-13
SLIDE 13

KEY HIGHLIGHTS & ROADMAP TO SUCCESS

Competitive advantage – Leveraging a portfolio of well known proprietary software solutions with high quality imaging hardware products across a large customer base and established distribution network

13

Significant growth & market size – Growth through recurring cloud based SaaS imaging model, focus on DSO, dental specialty and government markets leveraging existing sales and marketing platform to support digital imaging product line expansion Right space, right time – Leveraging the growth of the software and dental imaging / hardware space – poised for future company growth with market Rapid value creation – Through organic growth, recurring revenue opportunities and future accretive acquisitions /strategic partnerships Proven management team – Extensive experience in the dental industry with experience in DSO market. Reputation for guiding dental companies from early growth stages to becoming industry leaders

slide-14
SLIDE 14

Investor Relations Contact Glen Akselrod Bristol Capital Tel: 905-326-1888 X1 glen@bristolir.com www.bristolir.com

580 Hornby Street, Unit 810 Vancouver, British Columbia V6C 2E7 844.952.7327 | www.leddental.com

See the difference